SCHEMBL4611268

SCHEMBL4611268

Nc1c(F)cc(CC(=O)O)cc1F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRP O00591 2/20 0.44
GABRD O14764 2/20 0.44
GABRA1 P14867 2/20 0.44
GABRB1 P18505 2/20 0.44
GABRG2 P18507 2/20 0.44
GABRB3 P28472 2/20 0.44
GABRA5 P31644 2/20 0.44
GABRA3 P34903 2/20 0.44
GABRA2 P47869 2/20 0.44
GABRB2 P47870 2/20 0.44
GABRA4 P48169 2/20 0.44
GABRE P78334 2/20 0.44
GABRA6 Q16445 2/20 0.44
GABRG1 Q8N1C3 2/20 0.44
GABRG3 Q99928 2/20 0.44
GABRQ Q9UN88 2/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
AKR1B1 P15121 1/20 0.43
LMNA P02545 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL908287 0.82 CES2 (0.46) AKR1B1LMNAGAATSHRKDM4E
SCHEMBL299357 0.80 GAA (0.47) AKR1B1LMNAGAATSHRKDM4E
SCHEMBL25327233 0.78 THRB (0.46) AKR1B1LMNAGAATSHRKDM4E
SCHEMBL26729959 0.78 HDAC1 (0.44) HDAC1HDAC6AKR1B1LMNAGAA
SCHEMBL2728544 0.78 GAA (0.50) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL30192663 0.78 GAA (0.50) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL1000775 0.77 GABRP (0.47) GABRPGABRDGABRA1GABRB1GABRG2
Methane SCHEMBL28521569 0.76 GAA (0.48) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL583915 0.75 AKR1B1 (0.60) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL29009790 0.75 RXRA (0.50) AKR1B1LMNAGAATSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9896417-B2 Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt,hydrate or solvate thereof MACROPHAGE PHARMA LIMITED (GB) 2018-02-20 US disclosed
US-9896417-B2 Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt,hydrate or solvate thereof MACROPHAGE PHARMA LIMITED (GB) 2018-02-20 US disclosed
US-20160297760-A1 TERT-BUTYL N-[2-ETHYL]-L-ALANINATE OR A SALT,HYDRATE OR SOLVATE THEREOF MACROPHAGE PHARMA LIMITED (GB) 2016-10-13 US disclosed
US-20160297760-A1 TERT-BUTYL N-[2-ETHYL]-L-ALANINATE OR A SALT,HYDRATE OR SOLVATE THEREOF MACROPHAGE PHARMA LIMITED (GB) 2016-10-13 US disclosed
US-8252833-B2 Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as EP4 receptor agonists GLAXO GROUP LIMITED (GB) 2012-08-28 US disclosed
EP-2457897-A1 BENZO (F) ISOINDOL-2-YLPHENYL ACETIC ACID DERIVATIVES AS EP4 RECEPTOR AGONISTS Glaxo Group Limited (GB) 2012-05-30 EP disclosed
EP-1979316-A1 BENZO (F) ISOINDOL-2-YLPHENYL ACETIC ACID DERIVATIVES AS EP4 RECEPTOR AGONISTS GLAXO GROUP LIMITED (GB) 2008-10-15 EP disclosed
WO-2007088190-A1 BENZO (F) ISOINDOL-2-YLPHENYL ACETIC ACID DERIVATIVES AS EP4 RECEPTOR AGONISTS GLAXO GROUP LIMITED (GB) 2007-08-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160297760-A1 TERT-BUTYL N-[2-ETHYL]-L-ALANINATE OR A SALT,HYDRATE OR SOLVATE THEREOF MAPK1, MAPK6, MAPK15 GABRP 4679/4885GABRD 4688/4885GABRA1 4637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.